Bafna Pharmaceuticals Limited manufactures and sells medicines and drugs in India and internationally. The company offers its products in various therapeutic areas comprising anti-bacterials, anti TB, antifungal, antimalarials, antiprotozoals, antidiarrhoeals / antidysentrics, anthelmintics, anti-inflammatories, analgesics / antipyretics / antirhumatoid / antispasmodics, diuretics, anti-anginals /A298, anti-thrombotics / antiplatelets, lipid lowering agents, cardioglycoside, antiulcerants / gastroenterologicals, anti-emetics / labyrinthine sedatives, and appetite stimulants. It also provides oral hypoglycemic agents (diabetologicals), anti-obesity, anti-allergics (antihistamines), cough cold preparations / expectorants, antiasthmatics / bronchodilators, anxiolytics, hypnotics, anti-depressants, anti-psychotics / antimigrane, anti-epileptics / antivertigo, anti-parkinsons, nutraceuticals / anti-oxidants / dietary supplements / vitamins, haematinics, immunosuppressants, haemorrheologicals, biphosphosphonates, and lipid lowering agent / nutritional, as well as drugs for erectile dysfunction. The company sells products primarily under OMERAN, OLMEBAF, LAVOV, ALENBON, PREJOTAC, IRAP, POCYM/POCYM-S, IVAB, COBAXINE, and AFENAC bands. In addition, it offers contract research and manufacturing services. The company was founded in 1981 and is based in Chennai, India.

Key Statistics